-
June 25, 2021 First-Of-Its-Kind Ketamine Prescribing Service Now Available to PsychotherapistsA new first-of-its-kind ketamine prescribing service comes to independent psychotherapists using the dissociative with their...
-
June 17, 2021 Extended-Release Ketamine Effective in Patients With Treatment-Resistant DepressionKetamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral...
-
June 17, 2021 Bringing Next-Gen Depression Treatment to Market: PharmaTher’s Ketamine PatchPsychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other...
-
June 15, 2021 University of Calgary Creates Canada’s First Chair for Psychedelic ResearchCanada gets its first chair for psychedelic research thanks to private citizen funding to the...
-
June 2, 2021 Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of KetamineA new device may help Cybin better understand the psychedelic impact of the drug ketamine...
-
May 17, 2021 FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease TreatmentResearch into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects...
-
May 7, 2021 New Treatment Potential for Depressed, Suicidal Patients With Ketamine, Says ExpertThere's new hope for depressed and suicidal patients with ketamine therapy, says University of Alabama...
-
May 6, 2021 NIMH Supports 8 Interventions for Severe Suicide Risk Including Ketamine, EsketamineNew treatment interventions approved by NIMH for use with high-suicide risks include two novel ketamine...
-
May 6, 2021 Ketamine Effectively Treats Persistent Migraine Headaches: StudyA nasal spray of ketamine proved to be highly effective at treating a type of...
-
April 28, 2021 PharmaTher Files Patent on Ketamine for Diabetes and Obesity TreatmentKetamine may be a useful treatment for diabetes and obesity, according to a new patent...
